GB463698A - Process for the manufacture of a vitamin preparation - Google Patents

Process for the manufacture of a vitamin preparation

Info

Publication number
GB463698A
GB463698A GB2750635A GB2750635A GB463698A GB 463698 A GB463698 A GB 463698A GB 2750635 A GB2750635 A GB 2750635A GB 2750635 A GB2750635 A GB 2750635A GB 463698 A GB463698 A GB 463698A
Authority
GB
United Kingdom
Prior art keywords
vitamin
acetone
acid
hydrolysis
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2750635A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IG Farbenindustrie AG
Original Assignee
IG Farbenindustrie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IG Farbenindustrie AG filed Critical IG Farbenindustrie AG
Priority to GB2750635A priority Critical patent/GB463698A/en
Publication of GB463698A publication Critical patent/GB463698A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Extraction Or Liquid Replacement (AREA)

Abstract

Vitamin H is extracted in a water soluble form from raw materials by a hydrolysis at temperatures above 100 DEG C. and under pressure, preferably at a temperature between 120 and 300 DEG C. Raw materials mentioned as particularly rich in vitamin H are the liver and kidneys, although various other animal organs also contain the vitamin in lesser amounts. The hydrolysis is always conducted in aqueous medium, and advantageously in the presence of water soluble organic diluents such as acetone and methyl and ethyl alcohol. In addition to the organic diluents it is also preferred to conduct the hydrolysis in the presence of electrolytes. These may be neutral such as sodium chloride or sulphate, ammonium chloride or sulphate, or potassium chloride, or acid such as dilute hydrochloric, sulphuric, phosphoric or acetic acid, or acid reacting salts such as sodium or potassium bisulphate, zinc chloride or iron sulphate, or alkaline such as sodium, potassium or magnesium hydroxide, baryta, milk of lime, sodium or potassium carbonate or acetate, or secondary or tertiary alkali metal phosphates. The electrolytes particularly the alkali metal phosphates may also act as buffer substances. Instead of the crude raw materials there may be used preparations in which the vitamin H has been partially set free, but to an insufficient extent for practical purposes. Such preparations may be obtained by subjecting raw materials containing the vitamin to a papaene digestion, or to a hydrolysis in a neutral medium at an elevated temperature under pressure. After hydrolysis the product may be further purified by, for example, the removal of insoluble substances, or by absorption on an absorbent such as charcoal followed by elutriation with either acetone, aqueous pyridine, or mixtures containing pyridine, acetone, and methyl, ethyl, or isopropyl alcohol. Other purification methods include a precipitation of ineffective accompanying substances by means of heavy metal salts such as mercury chloride or sulphate, uranyl acetate, or lead-acetate, or alternatively the vitamin component may be precipitated by means of phosphotungstic acid and the precipitate decomposed by baryta or milk of lime. Acid or alkaline hydrolysis is preferred to neutral hydrolysis since the vitamin becomes thereby soluble not only in water, but also in organic solvents. After either an acid or an alkaline hydrolysis neutralization is necessary before separation of the vitamin with organic solvents. This separation may be carried out either by disintegration with water soluble organic solvents or by extraction with water insoluble solvents. In the former case the active principle is dissolved, and the inactive components separate, usually in the form of an oil. Examples of water soluble solvents are ketones such as acetone, methyl-ethyl, and di-ethyl ketone, and alcohols such as methanol, ethanol, or isopropanol. Examples of water insoluble solvents are pentanol, isopentanol, the butanols, and carboxylic esters such as ethyl and methyl acetates. The solutions of the vitamin in organic solvents may, if desired, be again subjected to the purification processes described above. A dry vitamin H preparation may be obtained by the evaporation of any of the solutions prepared as described above. In examples: (1) Finely minced kidneys are heated with dilute hydrochloric acid at 140 DEG C. under 3,5 atmospheres for 3 hours. The liquor is drained and the treatment repeated. The combined extracts are concentrated and filtered. (2) Liver is exhaustively extracted with 40 per cent alcohol, dried, and heated at 160 DEG C. under 6 atmospheres with water. The residue is filtered and the extract concentrated. (3) Liver powder is heated for 6 hours with water at 180 DEG C. under pressure, filtered, concentrated, and then boiled with dilute sulphuric acid for 6 hours. The product is neutralized and acetone added. The acetone solution is separated from the dark oil, and concentrated. A mixture of acetone and propanol may be used instead of acetone. If desired a precipitation with phosphotungstic acid followed by decomposition with baryta may be interposed between the acid hydrolysis and the acetone treatment. (4) Liver powder is heated with dilute sulphuric acid at 160 DEG C. under pressure for 4 hours, neutralized without filtering with caustic soda, and after concentration, treated with ethyl acetate. The ester solution is separated from the dark sediment and concentrated. (5) Liver powder is heated at 150 DEG C. under pressure for 4 hours with dilute caustic soda. The gelatinous mass is washed with water, neutralized, concentrated, and then acetone is added. The oily sediment is separated and the clear layer evaporated to dryness, dissolved in water and filtered from sediment.
GB2750635A 1935-10-04 1935-10-04 Process for the manufacture of a vitamin preparation Expired GB463698A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2750635A GB463698A (en) 1935-10-04 1935-10-04 Process for the manufacture of a vitamin preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2750635A GB463698A (en) 1935-10-04 1935-10-04 Process for the manufacture of a vitamin preparation

Publications (1)

Publication Number Publication Date
GB463698A true GB463698A (en) 1937-04-05

Family

ID=10260672

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2750635A Expired GB463698A (en) 1935-10-04 1935-10-04 Process for the manufacture of a vitamin preparation

Country Status (1)

Country Link
GB (1) GB463698A (en)

Similar Documents

Publication Publication Date Title
GB413714A (en) Improvements in the manufacture and production of pure lecithin
US2989438A (en) Process of purifying heparin, and product produced therefrom
GB463698A (en) Process for the manufacture of a vitamin preparation
US2701255A (en) Organic products from lignocellulose
GB566351A (en) Improvements in or relating to processes for the extraction and purification of insulin
GB464370A (en) Improvements in and relating to processes for the purification of crude phosphoric acid
GB1020453A (en) A process for the concentration and recovery of niobium and tantalum values from siliceous slags
US2193523A (en) Vitamin preparation
US2794035A (en) Process of producing ergosterol and cerebrin
US1976175A (en) Process of preparing adenosine phosphoric acid
US1468251A (en) Process for obtaining vitamines
US2559305A (en) Manufacture of tanning substances
GB280969A (en) Improved process for the purification of lactic acid
GB469157A (en) Process for the manufacture of laevo-ascorbic acid
GB801553A (en) The production of edible protein products from fish solubles
US2174532A (en) Process for separating phenolic bodies
US1942177A (en) Process for recovering alkaloids from cocoa products
US2136397A (en) Oestrogenous products and methods of producing the same
US1942160A (en) Process for recovering alkaloids from cocoa products
GB610814A (en) Process of recovering vanillic acid from lignin
GB626641A (en) A process for the production and purification of common salt and other components from brine, including the dehydration of glauber salt
US2476490A (en) Production of trifluoro acetic acid
GB366940A (en) A process for preparing liquids containing active principles or hormones from parathyroid glands
GB199400A (en) Process for the manufacture of the cardiac glucoside of bulbus scillae
GB496248A (en) Pancreas-derived product and process of producing it